JPS63238019A - 抗鬱剤 - Google Patents

抗鬱剤

Info

Publication number
JPS63238019A
JPS63238019A JP63044060A JP4406088A JPS63238019A JP S63238019 A JPS63238019 A JP S63238019A JP 63044060 A JP63044060 A JP 63044060A JP 4406088 A JP4406088 A JP 4406088A JP S63238019 A JPS63238019 A JP S63238019A
Authority
JP
Japan
Prior art keywords
group
antidepressant
pyrrolidin
benzyl
atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP63044060A
Other languages
English (en)
Japanese (ja)
Inventor
エーリッヒ　レール
ヴォルフ　ディートリッヒ　ベヒテル
アシュトリート　シュシュテル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim GmbH
Original Assignee
Boehringer Ingelheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim GmbH filed Critical Boehringer Ingelheim GmbH
Publication of JPS63238019A publication Critical patent/JPS63238019A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Dental Preparations (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP63044060A 1987-02-27 1988-02-26 抗鬱剤 Pending JPS63238019A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3706399.5 1987-02-27
DE19873706399 DE3706399A1 (de) 1987-02-27 1987-02-27 Mittel mit antidepressiver wirkung

Publications (1)

Publication Number Publication Date
JPS63238019A true JPS63238019A (ja) 1988-10-04

Family

ID=6321945

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63044060A Pending JPS63238019A (ja) 1987-02-27 1988-02-26 抗鬱剤

Country Status (14)

Country Link
US (2) US4931435A (https=)
EP (1) EP0280290B1 (https=)
JP (1) JPS63238019A (https=)
KR (1) KR880009647A (https=)
AT (1) ATE71300T1 (https=)
AU (1) AU605554B2 (https=)
CA (1) CA1317229C (https=)
DE (2) DE3706399A1 (https=)
DK (1) DK102988A (https=)
GR (1) GR3003657T3 (https=)
HU (1) HU200919B (https=)
IL (1) IL85560A (https=)
NZ (1) NZ223670A (https=)
ZA (1) ZA881366B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489354B1 (en) 1999-03-02 2002-12-03 Merck & Co., Inc. 3-alkyl substituted pyrrolidine modulators of chemokine receptor activity
WO2000051607A1 (en) 1999-03-02 2000-09-08 Merck & Co., Inc. 3-cyclopropyl and 3-cyclobutyl pyrrolidine modulators of chemokine receptor activity
AU3389300A (en) * 1999-03-02 2000-09-21 Merck & Co., Inc. Pyrrolidine modulators of chemokine receptor activity
TW200517114A (en) 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3301759A (en) * 1965-05-26 1967-01-31 Robins Co Inc A H Analeptic compositions and method
CA1115212A (en) * 1978-02-10 1981-12-29 Emilio Kyburz Pyrrolidine derivatives
DE3326724A1 (de) * 1983-07-25 1985-02-07 Boehringer Ingelheim KG, 6507 Ingelheim In 1-stellung substituierte 4-hydroxymethyl-pyrrolidinone, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen und zwischenprodukte
DE3336024A1 (de) * 1983-10-04 1985-04-18 Boehringer Ingelheim KG, 6507 Ingelheim 4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel

Also Published As

Publication number Publication date
AU1235288A (en) 1988-09-01
HUT46535A (en) 1988-11-28
DE3706399A1 (de) 1988-09-08
DE3867501D1 (de) 1992-02-20
KR880009647A (ko) 1988-10-04
ZA881366B (en) 1989-10-25
EP0280290B1 (de) 1992-01-08
US4931435A (en) 1990-06-05
CA1317229C (en) 1993-05-04
DK102988D0 (da) 1988-02-26
HU200919B (en) 1990-09-28
GR3003657T3 (https=) 1993-03-16
ATE71300T1 (de) 1992-01-15
AU605554B2 (en) 1991-01-17
IL85560A0 (en) 1988-08-31
US5217967A (en) 1993-06-08
NZ223670A (en) 1990-12-21
DK102988A (da) 1988-08-28
IL85560A (en) 1991-12-12
EP0280290A2 (de) 1988-08-31
EP0280290A3 (en) 1989-08-09

Similar Documents

Publication Publication Date Title
DE3717561A1 (de) Indol-, isochinolin- und benzazepinderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
KR0155543B1 (ko) 1-[모노-또는 비스(트리플루오로메틸)-2-피리디닐]피페라진을 함유한 약학조성물
JPS59106491A (ja) ベンゾキサジン化合物
DE2638184A1 (de) Substituierte phenyl-piperazin-n- oxide, verfahren zu deren herstellung und sie enthaltende arzneimittel
DD201305A5 (de) Verfahren zur herstellung von in 7-stellung substituierten benzopyranen
CH646696A5 (de) Dibenzazepine, ihre herstellung und verwendung.
JPH0517904B2 (https=)
FR2501506A1 (fr) Compositions pharmaceutiques a action anorexigene contenant des derives de la tetrahydropyridine
DE2733817A1 (de) 2-benzylpyrrolidine, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
JPS63238019A (ja) 抗鬱剤
JPH06511231A (ja) ２−（ピロリジニル−１−メチル）−ピペリジン誘導体およびκ受容体アゴニストとしてのその使用
US3328249A (en) Process for counteracting depressive states
JPH0753376A (ja) 強迫疾患の治療用医薬を製造するためのｎ−（ピリジニル）−１ｈ−インドール−１−アミンの使用
US4177291A (en) Compounds having antidepressive activity
JPH02138123A (ja) 心不全治療用医薬組成物
US3496186A (en) 2-aminomethyl benzofuran derivatives
US3868463A (en) Method of treating arrhythmia
US3218232A (en) Method for relieving depression and composition therefor
KR100226328B1 (ko) 4-(4-또는6-(트리플루오로메틸-2-피리디닐))-1-피페라지닐알킬치환된락탐
NZ207289A (en) N-(m-trifluoromethylphenyl)-n-propargylpiperazine and pharmaceutical compositions
US4954516A (en) Use of 1-benzyl-aminoalkyl-pyrrolidinones as antidepressants
CZ372792A3 (en) Pyrrolylbenzodiazepinones, processes of their preparation and medicaments based thereon
US4105796A (en) Pharmaceutical compositions containing racemic or optically active 1-(2,6-dimethyl-phenoxy)-2-methylamino-propane and method of use
US3472868A (en) 1-(2-5-dioxo-pyrrolidino-4-(perhydroazepino)-butyne-2
US4874761A (en) 4-arylcarbonyl-1-[(4-morpholinyl)-lower-alkyl]-1H-indoles